In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Podden och tillhörande omslagsbild på den här sidan tillhör Goldman Sachs. Innehållet i podden är skapat av Goldman Sachs och inte av, eller tillsammans med, Poddtoppen.
